Advocacy
Highlights of Comments, Letters, Testimony, and Policy Papers
- Letter to ADM Levine: Department of Health and Human Services’ Giving = Living campaign
- Letter to the New York State Department of Health Commissioner: New York’s Clinical Laboratory Regulations
- Together toward a broader European plasma donation ecosystem
- Plasma donation: New thinking to serve Europe’s patients — Practices & approaches for countries
- CDC Advisory Committee on Immunization Practices Comments on Vaccine Prioritization
- U.S. International Trade Commission Testimony on COVID-19 Related Goods
- International Pricing Index Model for Medicare Part B Comments
- Senate of Canada Standing Committee on Social Affairs, Science, and Technology Testimony on Bill S-252
- Proposals for revision of donor deferral criteria in the context of the COVID-19 situation in order to maintain access to plasma-derived medicinal products for patients in EU
- PPTA Supports California AB 392
- Proposed Urgent Regulatory Actions to Increase Source Plasma Collections
- Europe Needs to Collect More Plasma
- Physicians in European Plasma Collection Centers
- Plasma donation: New thinking to serve Europe’s patients — Practices & approaches for countries